Aprea Therapeutics, Inc.

Q1 2020 13F Holders

Symbol: APRE
CUSIP: 03836J102
Type: Equity
Class: COM
Num filings: 52
Total reported value, excl. options: $468 M

Compare 2020 Q1 to

Manager	Report Date	Value ($000)	Shares	Option Type